A double-blind, randomized, crossover phase I pharmacokinetic study of Tecarfarin in patients with chronic kidney disease and matched healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Tecarfarin (Primary) ; Warfarin
- Indications Thromboembolism
- Focus Adverse reactions; Pharmacokinetics
- 09 Feb 2017 Results published in the Thrombosis and Haemostasis.
- 15 Sep 2016 New trial record
- 25 Aug 2016 Results published in an Armetheon media release.